IBDEI0HX ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8675,2)
 ;;=^266752
 ;;^UTILITY(U,$J,358.3,8676,0)
 ;;=099.3^^52^585^82
 ;;^UTILITY(U,$J,358.3,8676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8676,1,3,0)
 ;;=3^Reiter's Disease
 ;;^UTILITY(U,$J,358.3,8676,1,4,0)
 ;;=4^099.3
 ;;^UTILITY(U,$J,358.3,8676,2)
 ;;=^104534
 ;;^UTILITY(U,$J,358.3,8677,0)
 ;;=112.89^^52^585^5
 ;;^UTILITY(U,$J,358.3,8677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8677,1,3,0)
 ;;=3^Candida,Oth
 ;;^UTILITY(U,$J,358.3,8677,1,4,0)
 ;;=4^112.89
 ;;^UTILITY(U,$J,358.3,8677,2)
 ;;=^87368
 ;;^UTILITY(U,$J,358.3,8678,0)
 ;;=136.1^^52^585^1
 ;;^UTILITY(U,$J,358.3,8678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8678,1,3,0)
 ;;=3^Behcet's Disease
 ;;^UTILITY(U,$J,358.3,8678,1,4,0)
 ;;=4^136.1
 ;;^UTILITY(U,$J,358.3,8678,2)
 ;;=^13205
 ;;^UTILITY(U,$J,358.3,8679,0)
 ;;=190.3^^52^585^11
 ;;^UTILITY(U,$J,358.3,8679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8679,1,3,0)
 ;;=3^Conjunctiva Malig Neopl
 ;;^UTILITY(U,$J,358.3,8679,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,8679,2)
 ;;=^267274
 ;;^UTILITY(U,$J,358.3,8680,0)
 ;;=198.89^^52^585^91
 ;;^UTILITY(U,$J,358.3,8680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8680,1,3,0)
 ;;=3^Uveal Metastasis
 ;;^UTILITY(U,$J,358.3,8680,1,4,0)
 ;;=4^198.89
 ;;^UTILITY(U,$J,358.3,8680,2)
 ;;=^267330
 ;;^UTILITY(U,$J,358.3,8681,0)
 ;;=202.80^^52^585^64
 ;;^UTILITY(U,$J,358.3,8681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8681,1,3,0)
 ;;=3^Lymphoma,Extranod/Solid Org,Unspec Site
 ;;^UTILITY(U,$J,358.3,8681,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,8681,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,8682,0)
 ;;=224.3^^52^585^12
 ;;^UTILITY(U,$J,358.3,8682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8682,1,3,0)
 ;;=3^Conjunctiva,Benign Neopl
 ;;^UTILITY(U,$J,358.3,8682,1,4,0)
 ;;=4^224.3
 ;;^UTILITY(U,$J,358.3,8682,2)
 ;;=^267673
 ;;^UTILITY(U,$J,358.3,8683,0)
 ;;=238.8^^52^585^68
 ;;^UTILITY(U,$J,358.3,8683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8683,1,3,0)
 ;;=3^Neopl,Uncert Behavior,Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,8683,1,4,0)
 ;;=4^238.8
 ;;^UTILITY(U,$J,358.3,8683,2)
 ;;=^267779
 ;;^UTILITY(U,$J,358.3,8684,0)
 ;;=360.11^^52^585^92
 ;;^UTILITY(U,$J,358.3,8684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8684,1,3,0)
 ;;=3^Uveitis Sympathetic
 ;;^UTILITY(U,$J,358.3,8684,1,4,0)
 ;;=4^360.11
 ;;^UTILITY(U,$J,358.3,8684,2)
 ;;=^85809
 ;;^UTILITY(U,$J,358.3,8685,0)
 ;;=360.12^^52^585^74
 ;;^UTILITY(U,$J,358.3,8685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8685,1,3,0)
 ;;=3^Panuveitis
 ;;^UTILITY(U,$J,358.3,8685,1,4,0)
 ;;=4^360.12
 ;;^UTILITY(U,$J,358.3,8685,2)
 ;;=^89553
 ;;^UTILITY(U,$J,358.3,8686,0)
 ;;=360.13^^52^585^51
 ;;^UTILITY(U,$J,358.3,8686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8686,1,3,0)
 ;;=3^Endophthalmitis,Parasitic
 ;;^UTILITY(U,$J,358.3,8686,1,4,0)
 ;;=4^360.13
 ;;^UTILITY(U,$J,358.3,8686,2)
 ;;=^40618
 ;;^UTILITY(U,$J,358.3,8687,0)
 ;;=360.30^^52^585^54
 ;;^UTILITY(U,$J,358.3,8687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8687,1,3,0)
 ;;=3^Hypotony,Unspec
 ;;^UTILITY(U,$J,358.3,8687,1,4,0)
 ;;=4^360.30
 ;;^UTILITY(U,$J,358.3,8687,2)
 ;;=^268556
 ;;^UTILITY(U,$J,358.3,8688,0)
 ;;=363.00^^52^585^8
 ;;^UTILITY(U,$J,358.3,8688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8688,1,3,0)
 ;;=3^Chorioretinitis,Focal,Unspec
 ;;^UTILITY(U,$J,358.3,8688,1,4,0)
 ;;=4^363.00
 ;;^UTILITY(U,$J,358.3,8688,2)
 ;;=^268662
 ;;^UTILITY(U,$J,358.3,8689,0)
 ;;=363.10^^52^585^7
 ;;^UTILITY(U,$J,358.3,8689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8689,1,3,0)
 ;;=3^Chorioretinitis,Disseminated
 ;;^UTILITY(U,$J,358.3,8689,1,4,0)
 ;;=4^363.10
